CLEVELAND, Aug. 13 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (Pink Sheets: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced it will be releasing its operating results for the second quarter and first-half of 2009 on Monday, August 17, 2009. In addition, DATATRAK's second quarter report as filed with Pink OTC Markets will be available on August 17(th) at www.pinksheets.com under the symbol: DATA. The Company has elected to follow the Pink OTC Markets OTCQX Guidelines for Providing Adequate Current Information, the highest tier and most transparent level of disclosure available to the Company.
In addition, as previously announced on August 3, 2009, the Company filed a Certificate and Notice of Termination of Registration on Form 15 with the Securities and Exchange Commission (the "SEC") today to effect (i) the voluntary deregistration of the Common Shares and related preferred share purchase rights (collectively, the "Securities") under Section 12(g) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"); and (ii) the suspension of its reporting obligations with respect to its Common Shares under Section 15(d) of the Exchange Act. The Company was eligible to deregister because there are fewer than 300 holders of record of its Securities. Upon the filing of the Form 15, the Company's obligations to file certain reports and forms with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, were immediately suspended. The Company expects the deregistration of its Securities to become effective 90 days after the filing of the Form 15.
The Company's Common Shares have been quoted on the Pink Sheets Electronic Markets since June 4, 2009. The Company anticipates that its Common Shares will continue to be quoted on the Pink Sheets Ele
|SOURCE DATATRAK International, Inc.|
Copyright©2009 PR Newswire.
All rights reserved